1052552-59-6

Basic information

• Product Name: (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride
• Synonyms: (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride
• CAS NO: 1052552-59-6
• Molecular Formula: C6H11Cl2N3S
• Molecular Weight: 228.14
• Mol File: 1052552-59-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride(1052552-59-6)
• EPA Substance Registry System: (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride(1052552-59-6)

Safety Data

• Hazardous Substances Data: 1052552-59-6(Hazardous Substances Data)

Usage

General Description

The chemical (2,3-Dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride, also known as Tozadenant, is an investigational drug that has been studied for its potential use in the treatment of Parkinson's disease. It belongs to a class of compounds known as adenosine A2A receptor antagonists, which are believed to have neuroprotective and anti-inflammatory properties. Tozadenant works by blocking the adenosine A2A receptors, which are involved in regulating the levels of dopamine in the brain. By doing so, it is thought to help reduce the motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia. Clinical trials have been conducted to evaluate its safety and efficacy, with promising results indicating its potential as a new treatment option for Parkinson's disease patients.